nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Transaminases increased—Thiotepa—sarcoma	0.0282	0.0282	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Mitoxantrone—sarcoma	0.0146	0.0146	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Dactinomycin—sarcoma	0.0144	0.0144	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Mitoxantrone—sarcoma	0.0125	0.0125	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Epirubicin—sarcoma	0.0114	0.0114	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—sarcoma	0.0105	0.0105	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Etoposide—sarcoma	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Dactinomycin—sarcoma	0.01	0.01	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Mitoxantrone—sarcoma	0.0098	0.0098	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Thiotepa—sarcoma	0.00972	0.00972	CcSEcCtD
Ceftaroline fosamil—Infestation—Thiotepa—sarcoma	0.00961	0.00961	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Thiotepa—sarcoma	0.00961	0.00961	CcSEcCtD
Ceftaroline fosamil—Renal failure—Thiotepa—sarcoma	0.00944	0.00944	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Thiotepa—sarcoma	0.00909	0.00909	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Vincristine—sarcoma	0.00893	0.00893	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Mitoxantrone—sarcoma	0.0087	0.0087	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Dactinomycin—sarcoma	0.00856	0.00856	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Thiotepa—sarcoma	0.00852	0.00852	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Thiotepa—sarcoma	0.00845	0.00845	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Mitoxantrone—sarcoma	0.00839	0.00839	CcSEcCtD
Ceftaroline fosamil—Renal failure—Mitoxantrone—sarcoma	0.00815	0.00815	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Thiotepa—sarcoma	0.00782	0.00782	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Thiotepa—sarcoma	0.00779	0.00779	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Mitoxantrone—sarcoma	0.00758	0.00758	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Vincristine—sarcoma	0.00755	0.00755	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Thiotepa—sarcoma	0.00751	0.00751	CcSEcCtD
Ceftaroline fosamil—Erythema—Thiotepa—sarcoma	0.00751	0.00751	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Vincristine—sarcoma	0.0075	0.0075	CcSEcCtD
Ceftaroline fosamil—Erythema—Dactinomycin—sarcoma	0.00745	0.00745	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Mitoxantrone—sarcoma	0.00745	0.00745	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Etoposide—sarcoma	0.00724	0.00724	CcSEcCtD
Ceftaroline fosamil—Anaemia—Thiotepa—sarcoma	0.00694	0.00694	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Vincristine—sarcoma	0.00694	0.00694	CcSEcCtD
Ceftaroline fosamil—Infestation—Etoposide—sarcoma	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Etoposide—sarcoma	0.0069	0.0069	CcSEcCtD
Ceftaroline fosamil—Anaemia—Dactinomycin—sarcoma	0.00689	0.00689	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—sarcoma	0.00679	0.00679	CcSEcCtD
Ceftaroline fosamil—Renal failure—Etoposide—sarcoma	0.00678	0.00678	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Etoposide—sarcoma	0.00653	0.00653	CcSEcCtD
Ceftaroline fosamil—Convulsion—Thiotepa—sarcoma	0.0065	0.0065	CcSEcCtD
Ceftaroline fosamil—Erythema—Mitoxantrone—sarcoma	0.00648	0.00648	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00635	0.00635	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—sarcoma	0.00629	0.00629	CcSEcCtD
Ceftaroline fosamil—Anaemia—Vincristine—sarcoma	0.00615	0.00615	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Etoposide—sarcoma	0.00612	0.00612	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Etoposide—sarcoma	0.00607	0.00607	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Thiotepa—sarcoma	0.00601	0.00601	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Thiotepa—sarcoma	0.006	0.006	CcSEcCtD
Ceftaroline fosamil—Anaemia—Mitoxantrone—sarcoma	0.00599	0.00599	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dactinomycin—sarcoma	0.00595	0.00595	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Thiotepa—sarcoma	0.00595	0.00595	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—sarcoma	0.00583	0.00583	CcSEcCtD
Ceftaroline fosamil—Convulsion—Vincristine—sarcoma	0.00577	0.00577	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Etoposide—sarcoma	0.00562	0.00562	CcSEcCtD
Ceftaroline fosamil—Convulsion—Mitoxantrone—sarcoma	0.00562	0.00562	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Etoposide—sarcoma	0.0056	0.0056	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Vincristine—sarcoma	0.00543	0.00543	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—sarcoma	0.00539	0.00539	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Vincristine—sarcoma	0.00533	0.00533	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Vincristine—sarcoma	0.00532	0.00532	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00529	0.00529	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00529	0.00529	CcSEcCtD
Ceftaroline fosamil—Pain—Thiotepa—sarcoma	0.00524	0.00524	CcSEcCtD
Ceftaroline fosamil—Constipation—Thiotepa—sarcoma	0.00524	0.00524	CcSEcCtD
Ceftaroline fosamil—Pain—Dactinomycin—sarcoma	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00518	0.00518	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Mitoxantrone—sarcoma	0.00514	0.00514	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Thiotepa—sarcoma	0.00501	0.00501	CcSEcCtD
Ceftaroline fosamil—Anaemia—Etoposide—sarcoma	0.00498	0.00498	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dactinomycin—sarcoma	0.00497	0.00497	CcSEcCtD
Ceftaroline fosamil—Urticaria—Thiotepa—sarcoma	0.00487	0.00487	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Thiotepa—sarcoma	0.00484	0.00484	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Thiotepa—sarcoma	0.00484	0.00484	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dactinomycin—sarcoma	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dactinomycin—sarcoma	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Vincristine—sarcoma	0.00469	0.00469	CcSEcCtD
Ceftaroline fosamil—Convulsion—Etoposide—sarcoma	0.00467	0.00467	CcSEcCtD
Ceftaroline fosamil—Pain—Vincristine—sarcoma	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Constipation—Vincristine—sarcoma	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—sarcoma	0.00457	0.00457	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00456	0.00456	CcSEcCtD
Ceftaroline fosamil—Pain—Mitoxantrone—sarcoma	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Constipation—Mitoxantrone—sarcoma	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Thiotepa—sarcoma	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Dactinomycin—sarcoma	0.00448	0.00448	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vincristine—sarcoma	0.00444	0.00444	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Etoposide—sarcoma	0.0044	0.0044	CcSEcCtD
Ceftaroline fosamil—Pruritus—Thiotepa—sarcoma	0.00433	0.00433	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00433	0.00433	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Etoposide—sarcoma	0.00431	0.00431	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—sarcoma	0.0043	0.0043	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Vincristine—sarcoma	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vincristine—sarcoma	0.00429	0.00429	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Etoposide—sarcoma	0.00427	0.00427	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—sarcoma	0.00423	0.00423	CcSEcCtD
Ceftaroline fosamil—Urticaria—Mitoxantrone—sarcoma	0.0042	0.0042	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Thiotepa—sarcoma	0.00419	0.00419	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mitoxantrone—sarcoma	0.00418	0.00418	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mitoxantrone—sarcoma	0.00418	0.00418	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dactinomycin—sarcoma	0.00416	0.00416	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—sarcoma	0.00406	0.00406	CcSEcCtD
Ceftaroline fosamil—Dizziness—Thiotepa—sarcoma	0.00405	0.00405	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Vincristine—sarcoma	0.004	0.004	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—sarcoma	0.00397	0.00397	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—sarcoma	0.00391	0.00391	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Ceftaroline fosamil—Vomiting—Thiotepa—sarcoma	0.0039	0.0039	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—sarcoma	0.00387	0.00387	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—sarcoma	0.00387	0.00387	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dactinomycin—sarcoma	0.00387	0.00387	CcSEcCtD
Ceftaroline fosamil—Rash—Thiotepa—sarcoma	0.00386	0.00386	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Thiotepa—sarcoma	0.00386	0.00386	CcSEcCtD
Ceftaroline fosamil—Headache—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Ceftaroline fosamil—Rash—Dactinomycin—sarcoma	0.00383	0.00383	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—sarcoma	0.0038	0.0038	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Etoposide—sarcoma	0.0038	0.0038	CcSEcCtD
Ceftaroline fosamil—Constipation—Etoposide—sarcoma	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Pain—Etoposide—sarcoma	0.00376	0.00376	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—sarcoma	0.00375	0.00375	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vincristine—sarcoma	0.00372	0.00372	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Ceftaroline fosamil—Nausea—Thiotepa—sarcoma	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—sarcoma	0.00362	0.00362	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mitoxantrone—sarcoma	0.00362	0.00362	CcSEcCtD
Ceftaroline fosamil—Nausea—Dactinomycin—sarcoma	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Etoposide—sarcoma	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vincristine—sarcoma	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—sarcoma	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—sarcoma	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—sarcoma	0.00353	0.00353	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—sarcoma	0.00352	0.00352	CcSEcCtD
Ceftaroline fosamil—Urticaria—Etoposide—sarcoma	0.0035	0.0035	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Etoposide—sarcoma	0.00348	0.00348	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Etoposide—sarcoma	0.00348	0.00348	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vincristine—sarcoma	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Rash—Vincristine—sarcoma	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vincristine—sarcoma	0.00342	0.00342	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Ceftaroline fosamil—Headache—Vincristine—sarcoma	0.0034	0.0034	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—sarcoma	0.00338	0.00338	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mitoxantrone—sarcoma	0.00336	0.00336	CcSEcCtD
Ceftaroline fosamil—Rash—Mitoxantrone—sarcoma	0.00334	0.00334	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mitoxantrone—sarcoma	0.00333	0.00333	CcSEcCtD
Ceftaroline fosamil—Headache—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—sarcoma	0.00327	0.00327	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Ceftaroline fosamil—Nausea—Vincristine—sarcoma	0.00323	0.00323	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—sarcoma	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Ceftaroline fosamil—Nausea—Mitoxantrone—sarcoma	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—sarcoma	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Pruritus—Etoposide—sarcoma	0.00311	0.00311	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Etoposide—sarcoma	0.00301	0.00301	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Ceftaroline fosamil—Dizziness—Etoposide—sarcoma	0.00291	0.00291	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—sarcoma	0.0029	0.0029	CcSEcCtD
Ceftaroline fosamil—Vomiting—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Ceftaroline fosamil—Rash—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Headache—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—sarcoma	0.00262	0.00262	CcSEcCtD
Ceftaroline fosamil—Nausea—Etoposide—sarcoma	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
